Loading clinical trials...
Loading clinical trials...
19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB): A Randomized Prospective Trial
To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.
The 19Gauge core and 22Gauge core needles have both been used for EUS-LB with good success. Previous studies have reported good safety and tissue adequacy with both the needles, but the head-on comparison between these two needles is lacking. This is a prospective randomized trial comparing the biopsy specimen adequacy of 19Gauge versus 22Gauge core needles for EUS-LB.
Age
18 - 89 years
Sex
ALL
Healthy Volunteers
No
Geisinger Medical Center
Danville, Pennsylvania, United States
Start Date
April 30, 2021
Primary Completion Date
March 16, 2022
Completion Date
March 16, 2022
Last Updated
April 20, 2022
42
ACTUAL participants
19G FNB
PROCEDURE
22G FNB
PROCEDURE
Lead Sponsor
Geisinger Clinic
NCT07480057
NCT06181409
NCT06449339
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions